Other News

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

Rhythm by Comments are Disabled

Southlake, TX, July 25, 2024 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that the MyoVista® wavECGTM has been selected by the Innovation Value Institute as a technology which can drive the radical transformation of healthcare and has been invited to demonstrate and discuss the MyoVista wavECG at the 4th Digital Health Symposium at the United Nations General Assembly to be held in New York, USA in September 2024.

Continue Reading →

Patient Enrollment Commenced in Pivotal Phase 3 Trial of CardiAMP Cell Therapy for the Treatment of Ischemic Heart Failure

Coronary/Structural Heart by Comments are Disabled

SUNNYVALE, Calif., July 25, 2024 (GLOBE NEWSWIRE) — BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced today that the confirmatory Phase 3 trial of its autologous CardiAMP cell therapy product candidate for patients with ischemic heart failure of reduced ejection fraction (HFrEF) has commenced enrollment in the United States.

Continue Reading →

Imperative Care Announces Clinical Data from the Pivotal Imperative Trial Evaluating the Zoom Reperfusion System for the Treatment of Ischemic Stroke

Neuro by 0 comments

Late-Breaking Data Presented at SNIS Suggest Lower Rates of Rescue Therapy Than Prior Thrombectomy Trials; Rapid Reperfusion Time; High Rates of Reperfusion July 24, 2024 01:30 PM Eastern Daylight Time CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced that late-breaking data from the Imperative Trial were presented at the Society of […]

Continue Reading →

Access Vascular Prepares Catheter Location Technology for FDA Submission

Radiology by 0 comments

BILLERICA, Mass.–(BUSINESS WIRE)–Access Vascular, Inc. (AVI), a medical device company dedicated to reducing and eliminating common and costly vascular access complications with its novel MIMIX® catheter material, announced today that it is preparing to submit its HydroGUIDE™ catheter placement technology for U.S. Food & Drug Administration (FDA) clearance. “Combining the innovative […]

Continue Reading →

Kestra Medical Technologies Announces $196 Million Oversubscribed Financing Round

Financial by 0 comments

July 24, 2024 08:00 AM Eastern Daylight Time KIRKLAND, Wash.–(BUSINESS WIRE)–Kestra Medical Technologies, Inc., a privately held wearable medical device and digital healthcare company, today announced an oversubscribed $196 million funding round to support the expansion of their commercial organization and advance its mission of protecting at-risk patients with its […]

Continue Reading →

Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix

Coronary/Structural Heart Financial by 0 comments

July 24, 2024 04:15 PM Eastern Daylight Time IRVINE, Calif.–(BUSINESS WIRE)–Edwards Lifesciences (NYSE: EW) today announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth. Edwards has entered into an agreement to acquire JenaValve Technology, […]

Continue Reading →

Prevencio Granted U.S. Patent for Highly Accurate, Artificial Intelligence-driven Blood Test for Obstructive Coronary Artery Disease

Coronary/Structural Heart by 0 comments

July 24, 2024 09:07 AM Eastern Daylight Time KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc., a leader in AI-powered blood tests for cardiovascular diagnostics, announces that the United States Patent and Trademark Office has issued a patent for its highly accurate blood test, HART CADhs, which assesses a patient’s risk of obstructive coronary artery […]

Continue Reading →
1 … 278 279 280 281 282 … 1,380